December 12, 2017 / 2:27 AM / a year ago

BRIEF-Essa Pharma Reports Qtrly Loss Per Share Of $0.07

Dec 11 (Reuters) - ESSA Pharma Inc:

* ESSA PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2017

* QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.07‍​

* ‍CASH ON HAND AS AT SEPTEMBER 30, 2017 WAS $3.98 MILLION, WITH WORKING CAPITAL OF $1.28 MILLION​ Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below